Research Topics
Juggling Clinical Trial Supplies
May 15, 2012 9:54 am | by Ganesh Swaminath, PhD, General Manager, Pharmaceuticals, Global Healthcare,and Life Sciences Practice; Wipro Technologies, Chennai, India | Articles | CommentsClinical development is an integral part of launching new drugs to market, and is comprised mainly of conducting clinical trials and submitting the data for approval.
NovaDigm Wraps Up Second Study
May 14, 2012 11:31 am | News | CommentsNovaDigm Therapeutics announced the presentation of positive data for its NDV-3 vaccine program in a second Phase 1 study.
Positive Data from Schizophrenia Trial
May 14, 2012 11:28 am | News | CommentsOtsuka Pharmaceutical Co. Ltd. and H. Lundbeck A/S announced results from a Phase 3 clinical trial evaluating aripiprazole for the treatment of adults with schizophrenia.
Positive Results from Fissure Trial
May 14, 2012 11:24 am | News | CommentsVentrus Biosciences Inc. reported positive results from its Phase 3 clinical trial of diltiazem hydrochloride cream in patients with anal fissures.
Promethera Treating Patients with HepaStem
May 14, 2012 11:21 am | News | CommentsPromethera Biosciences has treated its first two patients with its innovative treatment based on allogeneic adult liver stem cell technology, HepaStem.
AesRx Starts Aes-103 Trial
May 14, 2012 11:17 am | News | CommentsAesRx LLC has begun a Phase 1/2a clinical trial of Aes-103 in patients with sickle cell disease. This trial is part of an ongoing collaboration with the National Institutes of Health.
Bioethics Experts Form Global "Collaboratory"
May 11, 2012 11:39 am | News | CommentsA team of bioethics experts has created ELSI 2.0, an international "collaboratory" to better respond to the global aspects of the ethical, legal and social implications (ELSI) of modern genomics.
TapImmune Beginning Phase 1 Trial
May 10, 2012 10:58 am | News | CommentsTapImmune Inc. has announced that following recent IRB approval a Phase 1 clinical trial on a novel set of HER2/neu Class II antigens will start at Mayo Clinic.
FDA Panel Backs Tofacitinib
May 10, 2012 10:14 am | by Matthew Perrone | News | CommentsFederal health advisers said that a first-of-a-kind drug from Pfizer appears to be safe and effective for patients with rheumatoid arthritis.
GTx Restarting Mid-Stage Trial
May 9, 2012 10:45 am | News | CommentsGTx Inc. announced that regulators are allowing it to restart clinical testing of its prostate cancer drug Capesaris. The company said it will start a new mid-stage trial of Capesaris during the third quarter of 2012.
CureXcell Meets Goals in Late-stage Study
May 8, 2012 11:11 am | News | CommentsMacrocure has achieved positive results for a Phase 4 trial of its lead product, CureXcell, for the treatment of hard-to-heal ulcers in a community care setting.
HT-100 Receives Orphan Status
May 8, 2012 11:00 am | News | CommentsHalo Therapeutics LLC announced that the European Commission has granted orphan medicinal product designation to HT-100 for the treatment of Duchenne muscular dystrophy.
Dalcetrapib Testing Halted
May 8, 2012 10:40 am | by Linda A. Johnson | News | CommentsA second experimental cholesterol medicine in a once-promising class of drugs meant to replace blockbusters such as Lipitor has failed in testing.
Curcumin Being Tested Against Cancer
May 7, 2012 11:39 am | News | CommentsCompounds found in curry are being investigated as a way of improving drug response in patients with advanced bowel cancer in a new study.
Study Compares Actemra Formulations
May 7, 2012 11:18 am | News | CommentsGenentech announced that the SUMMACTA study met its primary endpoint, showing comparable efficacy of subcutaneous Actemra to intravenous Actemra.
Pfizer Halts Lyrica Study
May 7, 2012 10:56 am | News | CommentsThe world's largest drugmaker, Pfizer, halted a late-stage study of its second-best selling drug, Lyrica, as a possible treatment for a nerve pain in HIV patients.
Memantine Doesn't Ease Alzheimer Agitation
May 4, 2012 11:16 am | News | CommentsThe first randomized controlled trial to assess the effectiveness of memantine, a drug prescribed for Alzheimer's disease, showed the drug does not ease clinically significant agitation in patients.
AVEO Releases Phase 2 Data
May 3, 2012 11:29 am | News | CommentsA Phase 2 study has compared a combination of ficlatuzumab and gefitinib to gefitinib monotherapy in previously untreated Asian subjects with non-small cell lung cancer.
Gilead Begins GS-1101 Trial
May 3, 2012 11:16 am | News | CommentsGilead Sciences Inc. announced that the first patient has been dosed in a Phase 3 clinical trial evaluating the efficacy and safety of GS-1101.
Quotient Receives Enterion Approval
May 2, 2012 11:42 am | News | CommentsQuotient Clinical has received approval of the final patent for its Enterion technology. This completes a portfolio of eight granted patents across North America and Europe.
Transdermal Compound Testing
May 1, 2012 12:06 pm | Product Releases | CommentsEMD Millipore introduced the Strat-M membrane for screening compounds and formulations via in vitro diffusion studies. The synthetic membrane can be used in place of human or animal skin.
Vyvanse Evaluated for Binge Eating
May 1, 2012 10:53 am | News | CommentsShire plc announced positive top-line results from a Phase 2 study to evaluate the safety and efficacy of Vyvanse in adults with binge eating disorder.
Quark to Begin Phase 2a Study
May 1, 2012 10:47 am | News | CommentsQuark Pharmaceuticals Inc. it has amended an existing exclusive licensing agreement with Pfizer in order to perform a Phase 2a clinical trial of PF-655 on patients with open-angle glaucoma.
Idenix Reports HCV Data
May 1, 2012 10:27 am | News | CommentsA JMP Securities analyst has upgraded Idenix Pharmaceuticals Inc. stock after Idenix reported new data on its experimental hepatitis C drugs.
FDA Approves Impotence Drug
April 30, 2012 11:11 am | News | CommentsThe Food and Drug Administration approved a new impotence drug, Vivus Inc.'s Stendra. Vivus is talking to potential marketing partners, or it may sell the drug to another company.
